Case # 4 Low-Grade Serous Carcinoma (Macropapillary) of the Ovary Arising in an Atypical Proliferative Serous Tumor

Similar documents
Current Concept in Ovarian Carcinoma: Pathology Perspectives

Low-grade serous neoplasia. Robert A. Soslow, MD

Borderline tumors. Borderline tumors. Serous borderline tumor are NOT benign. Low grade serous carcinoma: pathogenesis. Serous carcinoma: pathogenesis

The Origin of Pelvic Low-Grade Serous Proliferative Lesions

SEROUS TUMORS. Dr. Jaime Prat. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona

International Society of Gynecological Pathologists Symposium 2007

Original contribution

Survival Analysis and Prognosis for Patients with Serous and Mucinous Borderline Ovarian Tumors: 14-Year Experience from a Tertiary Center in Iran

Low-Grade Serous Ovarian Tumors Debra A. Bell, MD Mayo Clinic and Mayo Medical School Rochester, MN

Serous Borderline Tumors of the Ovary: Implants, Manifestations, Biology & New Insights in Progression

Ovarian serous tumors of low malignant potential

Bibliography. Serous Tumors of the Ovary. Nomenclature

Biomarker expression in normal fimbriae: Comparison of high- and low-grade serous ovarian carcinoma

Select problems in cystic pancreatic lesions

Epithelial Ovarian Cancer 8/2/2013. Tu-be or Not Tu-be: Is the Fallopian Tube the Source of Ovarian Cancer?

Borderline Ovarian Tumours. Andreas Obermair Brisbane

Published Ahead of Print on September 28, 2012 as /theoncologist

3 cell types in the normal ovary

Case 1. Pathology of gynecological cancer. What do we need to know (Case 1) Luca Mazzucchelli Istituto cantonale di patologia Locarno

Key Words. Borderline ovarian tumor Prognostic parameter Ultrasound Fertility Conservative surgery Recurrence

Patologia Molecular del Carcinoma de Ovario

Article begins on next page

Introduction. Agenda. Pathogenesis. Pathogenesis and Clinical Implications. Pathogenesis and Clinical Implications

3 cell types in the normal ovary

Clinical History USCAP Specialty Conference. Gynecologic Pathology Case 3

Section 1. Biology of gynaecological cancers: our current understanding

Institute of Pathology First Faculty of Medicine Charles University. Ovary

Endosalpingiosis. Case report

Gestione dei tumori borderline iniziali e avanzati nelle donne in età fertile

Invited Re vie W. Molecular genetics of ovarian carcinomas. Histology and Histo pathology

A Serous Borderline Tumor of the Fallopian Tube Detected Incidentally

Interpretation of p53 Immunostains. P53 Mutations are Ubiquitous in High Grade Serous Carcinoma. Diffuse strong positive nuclear staining

Mousa. Najat kayed &Renad Al-Awamleh. Nizar Alkhlaifat

of 20 to 80 and subsequently declines [2].

NIH Public Access Author Manuscript Am J Surg Pathol. Author manuscript; available in PMC 2012 November 1.

David Nunns on behalf of the Gynae Guidelines Group Date:

The Diagnostic Challenges of Low Grade and High Grade Tubo-Ovarian Serous Carcinomas. W Glenn McCluggage Belfast, Northern Ireland

Mucinous Tumors of the Ovary Beirut, Lebanon. Anaís Malpica, M.D. Professor Department of Pathology

Papillary Lesions of the Breast: WHO Update

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

TITLE: Elucidation of Molecular Alterations in Precursor Lesions of Ovarian Serous Carcinoma

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case 4 Diagnosis 2/21/2011 TGB

THE FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA AND NIFTP

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors

Disclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose

5/26/2016. Pelvic Serous Carcinoma: 2014 W.H.O. Update. Outline of Talk. Changes to 2014 WHO system for pelvic serous tumors

Bases biológicas del cáncer de ovario en el siglo XXI

Go Nakai 1*, Takashi Yamada 2, Kazuhiro Yamamoto 1, Yoshinobu Hirose 2, Masahide Ohmichi 3 and Yoshifumi Narumi 1

Large Colorectal Adenomas An Approach to Pathologic Evaluation

Presenter: Yeh-Han Wang M.D.

Background. Background. Background. Background 2/2/2015. Endometriosis-Associated Ovarian Cancer: Malignant Transformation of Endometriosis

A Survay on Appendiceal Involvement in Ovarian Mucinous Tumors

Characterizing Adnexal Masses: Pearls and Pitfalls 20 th Annual Summer Practicum SCBT-MR Jackson Hole August 11, 2010

FINALIZED SEER SINQ S MAY 2012

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS

Case Report Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination

Clinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease

What s (new) and Important in Reporting of Uterine Cancers Katherine Vroobel The Royal Marsden

H&E, IHC anti- Cytokeratin

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center

NIFTP: Histopathology of a Cytological Monkey Wrench. B. Wehrli

Gynaecological Malignancies

BREAST PATHOLOGY. Fibrocystic Changes

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Basement membrane in lobule.

3/27/2017. Pulmonary Pathology Specialty Conference. Disclosure of Relevant Financial Relationships. Clinical History:

بسم هللا الرحمن الرحيم. Prof soha Talaat

Salivary Glands 3/7/2017

Biology Response Controversies and Advances

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

Lavage of the uterine cavity as potential tool for diagnosis of epithelial ovarian cancer and its precursors

Dilemmas in Cytopathology and Histopathology

A Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Breast Pathology. Breast Development

Primary Mucinous Ovarian Cancer (PMOC) Michael Frumovitz

Cytyc Corporation - Case Presentation Archive - March 2002

Ovarian Clear Cell Carcinoma

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series

Cancer arising from Endometriosis and Its Clinical implications

Borderline Brenner tumor of the ovary: a case report with immunohistochemical and molecular study

Ovarian carcinoma classification. Robert A. Soslow, MD

Interactive Staging Bee

Breast pathology. 2nd Department of Pathology Semmelweis University

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines

64 YO lady THBSO for prolapse At gross : A 3 cm endometrial polyp in the fundus

Shina Oranratanaphan, Tarinee Manchana*, Nakarin Sirisabya

AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS

WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?

Transcription:

Case # 4 Low-Grade Serous Carcinoma (Macropapillary) of the Ovary Arising in an Atypical Proliferative Serous Tumor Robert J Kurman, M.D. Johns Hopkins University School of Medicine

Case History A 53 year old woman presented with a pelvic mass and underwent a total abdominal hysterectomy and bilateral salpingooophorectomy At surgery bilateral ovarian tumors were found one measuring 8 cm and the other 6 cm in greatest dimension Microscopically, the tumors were similar Slides were from one of the ovarian tumors

Issues to be Discussed Typical micropapillary serous carcinoma (MPSC) - Background Relationship of MPSC to low-grade serous carcinoma Molecular genetic findings Macropapillary variant Lymph node involvement Sampling

Issues to be Discussed Typical MPSC - Background

Can SBTs be divided into benign and malignant subtypes? Hierarchical Branching Atypical Proliferative Serous Tumor Nonhierarchical Branching Micropapillary Serous Carcinoma, Noninvasive Medusa Compared to APSTs, MPSCs had a significantly poorer outcome Burks et al Am J Surg Pathol 20:1319-1330, 1996

Microsoft

Atypical Proliferative Serous Tumor Noninvasive Micropapillary Serous Carcinoma

Noninvasive Micropapillary Serous Carcinoma Medusa Micropapillary Cribriform Cribriform

Issues to be Discussed Typical MPSC Relationship to low-grade serous carcinoma Molecular genetic findings

Intraepithelial MPSC with focus of early invasion Frankly Invasive MPSC

Frequency of Functional p53 and KRAS or BRAF Mutations in Ovarian Serous Tumors Tumor KRAS/BRAF p53 SBT * 31/51 (61%) 2/25 (8%) Low-grade Serous Ca 15/22 (68%) 1/12 (8%) High-grade Serous Ca 0/72 ( 0%) 18/35 (51%) * Includes Atypical Prolif Tumor and noninvasive MPSC I-M Shih et al

Frequency of Functional p53 and KRAS or BRAF Mutations in Ovarian Serous Tumors Tumor KRAS/BRAF p53 SBT * 31/51 (61%) 2/25 (8%) Low-grade Serous Ca 15/22 (68%) 1/12 (8%) High-grade Serous Ca 0/72 ( 0%) 18/35 (51%) * Includes Atypical Prolif Tumor and noninvasive MPSC I-M Shih et al

Pathogenesis of Low Grade Serous Carcinoma or Invasive MPSC APST Noninvasive LGSC Noninvasive LGSC with invasion Invasive LGSC

Low-grade Serous Carcinomas are relatively uncommon

The Usual Type of Serous Carcinoma High-grade

High-grade Serous Carcinoma Pathogenesis The precursors of highgrade serous carcinomas are not well characterized It has been proposed that they develop de novo From the surface epithelium or inclusion cysts Bell DA, Scully RE Cancer 73:1859-64,1994

xxxxxxxxxxxxxxx Low-grade pathway Borderline Low-grade carcinoma High-grade carcinoma High-grade pathway xxxxxxxxxxxxxxx

High-grade pathway High-grade carcinoma

Issues to be Discussed Typical MPSC Relationship to low-grade serous carcinoma Molecular genetic findings Macropapillary variant

Low-grade serous carcinoma, macropapillary type

Issues to be Discussed Typical MPSC Relationship to low-grade serous carcinoma Molecular genetic findings Macropapillary variant Lymph node involvement

Lymph Node Involvement Historically thought to have little if any prognostic significance Two types Endosalpingiosis Clusters of eosinophilic cells in lymph node sinuses

Lymph Node Involvement and Outcome 43 Patients No. of Series No. of Cases Last Known Status 25 63 43 pts, 6.5 yr mean FU 1 patient DOD Survival 98% Seidman JD, Kurman RJ Hum Pathol 31:539-557, 2000

Lymph Node Involvement Endosalpingiosis

Lymph Node Involvement In fact there are not two types of involvement but Three types Endosalpingiosis Clusters of eosinophilic cells in lymph node sinuses Metastatic carcinoma

The Debate Micropapillary Serous Tumors Borderline or Carcinoma?

Consensus The noninvasive micropapillary tumor compared to the typical SBT is more often associated with invasive as opposed to noninvasive implants and Has a higher rate of recurrence

Consensus There is no difference in survival between typical SBTs and MP tumors once corrected for the presence of invasive implants

Disagreement It has been reported that occasionally typical SBTs are associated with invasive implants Therefore some argue that the MP tumors should not be classified as carcinoma

Issues to be Discussed Typical MPSC Relationship to low-grade serous carcinoma Molecular genetic findings Macropapillary variant Lymph node involvement Sampling

Bilateral SBTs one 10 cm, the other 9 cm 10 blocks taken from each tumor Noninvasive Implant Invasive Implant

Sampling is very important An additional 10 blocks were obtained from each tumor A 1 cm MPSC was identified on each side

Do Invasive Implants Ever Arise from Atypical Proliferative Serous Tumors (Typical SBTs)? Very unlikely! Invasive implants allegedly associated with typical SBTs probably contain occult areas of carcinoma (micro or rarely macropapillary serous carcinoma) that were not sampled

Take Home Message Implants associated with typical SBTs are noninvasive for all practical purposes If implants appear to be invasive, obtain additional sections of the primary tumor If areas of MPSC are not found, question whether the implants are truly invasive

What is the Significance of the Micropapillary Pattern? Recognition of micropapillary tumors has elucidated the nature of SBTs They are not a distinct entity, separate from invasive carcinoma, but in fact are precursors of low-grade serous carcinoma

What is the Significance of the Micropapillary Pattern? New understanding of ovarian serous carcinogenesis Low-grade serous carcinomas develop slowly in a stepwise fashion from a morphologically recognizeable precursor (SBT) High-grade serous carcinomas develop rapidly without intermediate stages de novo

The difficulty is not so much in developing new ideas as in escaping from old ones John Maynard Keynes